Skip to Main Content
An official website of the United States government
Scheduled Maintenance: CDAS will be undergoing maintenance on Saturday, February 7th from 7:30 AM to 9:30 AM U.S. Eastern Standard Time for updates to the website. During this time you may experience intermittent downtime.

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
1021-1040 of 1488
Name Principal Investigator Institution Study Date Approved Project ID
Effect of bilater salpingo-oophorectomy on morbidity and mortality Amanda Black NCI, DCEG, EBP PLCO Mar 14, 2013 PLCO-19
Second Cancers Following Radiotherapy in Prostate Cancer Patients in the PLCO Amanda Black NCI, DCEG, EBP PLCO Mar 14, 2013 PLCO-18
Biliary Tract Cancers Pooling Project Jill Koshiol NCI, DCEG, IIB PLCO Mar 5, 2013 PLCO-17
Genetic Targeted Screening Prediction of Prostate Cancer Mortality A. Karim Kader University of California, San Diego PLCO Mar 5, 2013 PLCO-14
Evaluation of serum antibodies to Helicobacter pylori proteins and hepatobiliary cancers Gwen Murphy Imperial College London PLCO Mar 4, 2013 2013-0035
Genome wide epigenetic alteration study to identify biomarkers of smoking and bladder cancer risk Lee Moore NCI, DCEG, OEEB PLCO Mar 4, 2013 2013-0033
Anti-Mullerian Hormone and Prostate Cancer Risk Martha Sklavos NCI, DCEG, IIB PLCO Mar 4, 2013 2013-0008
Prostate Specific Antigen (PSA) Growth Curves: an Innovation to Improve Prostate Cancer Screening James Hebert University of South Carolina, Cancer Prevention and Control Program PLCO Feb 22, 2013 PLCO-15
Impact of Family History on Colorectal Cancer Incidence and Expression Robert Schoen University of Pittsburgh PLCO Jan 25, 2013 PLCO-13
Calcium intake and lung cancer: effect modification by sex and smoking status Yumie Takata Vanderbilt University PLCO Jan 24, 2013 PLCO-11
Mortality and Morbidity Following Prostate Biopsy Paul Pinsky NCI, DCP, EDRG PLCO Jan 17, 2013 PLCO-12
Cancer history and melanoma risk Sonja Berndt NCI, DCEG, OEEB PLCO Dec 13, 2012 PLCO-10
Analysis of PSA, biopsy uptake predictive value and associated death in a prostate cancer screening programme Mathieu Boniol International Prevention Research Institute PLCO Dec 11, 2012 PLCO-8
Reconciling results of PSA screening efficacy using PLCO and ERSPC data: CISNET modeling project Ruth Etzioni Fred Hutchinson Cancer Research Center PLCO Dec 11, 2012 PLCO-9
BMI and risks of pancreatic cancer and multiple myeloma mortality in the African American BMI Pooling Project Cari Kitahara NCI, DCEG, NEB PLCO Dec 7, 2012 PLCO-7
Validation of a Risk Assessment Decision Rule for Epithelial Ovarian Cancer Nicole Urban Fred Hutchinson Cancer Research Center PLCO Dec 3, 2012 PLCO-6
Demographic, lifestyle, reproductive, and hormonal factors, medical history, and medication use in relation to thyroid cancer risk in the PLCO study Melissa Braganza NCI, DCEG, REB PLCO Nov 20, 2012 PLCO-5
Demographic, lifestyle, reproductive, and hormonal factors, medical history, and medication use in relation to glioma in the PLCO study Melissa Braganza NCI, DCEG, REB PLCO Nov 20, 2012 PLCO-4
Benign breast and reproductive conditions and thyroid cancer Melissa Braganza NCI, DCEG, REB PLCO Nov 20, 2012 PLCO-2
follow-up of abnormal CA 125 levels in patients in the PLCO trial Keith Terada University of Hawaii PLCO Nov 14, 2012 PLCO-3